Sequent Scientific Ltd.
BSE: 512529 | Sector: Health care |
NSE: SEQUENT | ISIN Code: INE807F01027 |
BSE 00:00 | 24 May | 125.60 |
-5.70 (-4.34%) |
OPEN
127.00 |
HIGH
128.25 |
LOW
123.50 |
NSE 00:00 | 24 May | 125.55 |
-5.70 (-4.34%) |
OPEN
126.90 |
HIGH
128.25 |
LOW
124.00 |
OPEN | 127.00 |
PREVIOUS CLOSE | 131.30 |
VOLUME | 205692 |
52-Week high | 336.40 |
52-Week low | 110.40 |
P/E | 246.27 |
Mkt Cap.(Rs cr) | 3,133 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Sequent Scientific Ltd. (SEQUENT) - Company Information
Visistha Traders & Finance Ltd has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12 2003....> More
COMPANY INFORMATION | |||||||
Non-Exec. & Independent Dir. : | Kausalya Santhanam | ||||||
Joint Managing Director : | Sharat Narasapur | ||||||
Company Secretary : | Krunal Shah | ||||||
Non-Exec & Non-Independent Dir : | Neeraj Bharadwaj | ||||||
Non-Exec & Non-Independent Dir : | Rahul Mukim | ||||||
Non-Exec & Non-Independent Dir : | Gregory John Andrews | ||||||
Non-Exec & Non-Independent Dir : | Fabian Kausche | ||||||
Chairman & Independent Directo : | Kamal K Sharma | ||||||
Non-Exec. & Independent Dir. : | Milind Sarwate | ||||||
AUDITOR : | S R B C & Co LLP | ||||||
IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
HOUSE NAME : | MNC Associate | ||||||
Registered office | |||||||
301 Dosti Pinnacle 3rd Floor, Plot E7 Road No 22 Wagle Indl,Thane,Maharashtra-400604 | |||||||
Ph : 91-022-41114777 | |||||||
WEBSITE : http://www.pidrugs.com | |||||||
E-mail : pidsecretarial@yahoo.co.in |
Quick Links for Sequent Scientific:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices